Filing Flows › Skinvisible (SKVI) › Q4 2025
Skinvisible (SKVI) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 31, 2026
Skinvisible (SKVI) reported revenue of $5K for the fourth quarter 2025 (Q4 2025) and 0% from the quarter before.
Skinvisible, Q4 2025: revenue $5K, net loss $258K, operating cash flow $2K. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5K | 0% | — |
| Operating profit | −$114K | — | — |
| Net earnings | −$258K | — | — |
| Operating cash flow | $2K | +277% | — |
What changed
Revenue was $5K in Q4 2025, roughly flat from the previous quarter.
Gross margin was 100.0%. Operating costs exceeded revenue by $114K, an operating margin of -2283.4%. The quarter ended with a net loss of $258K, wider than the previous quarter's $250K loss. Net interest and other expense of $144K was the main reason.
Operating cash flow was $2K. Non-cash charges added back $5K of depreciation and amortization. Working capital and other items added $255K.
Questions
What was Skinvisible's revenue in the fourth quarter 2025?
Skinvisible (SKVI) reported revenue of $5K for the fourth quarter 2025 (Q4 2025) and 0% from the quarter before.
Source: Skinvisible 10-K on SEC EDGAR.